Header Logo

Connection

SETH LERNER to Fenretinide

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Fenretinide.
SETH LERNER
Connection Strength
0.085
Fenretinide
  1. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
    View in: PubMed
    Score: 0.075
  2. Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol. 1998 Sep; 10(5):479-84.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.